AKRO logo

Akero Therapeutics (AKRO) Operating expenses

annual operating expenses:

$285.42M+$112.55M(+65.11%)
December 31, 2024

Summary

  • As of today (July 1, 2025), AKRO annual total operating expenses is $285.42 million, with the most recent change of +$112.55 million (+65.11%) on December 31, 2024.
  • During the last 3 years, AKRO annual operating expenses has risen by +$184.54 million (+182.92%).
  • AKRO annual operating expenses is now at all-time high.

Performance

AKRO Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROincome statement metrics

quarterly operating expenses:

$80.88M+$2.86M(+3.66%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AKRO quarterly total operating expenses is $80.88 million, with the most recent change of +$2.86 million (+3.66%) on March 31, 2025.
  • Over the past year, AKRO quarterly operating expenses has increased by +$20.93 million (+34.91%).
  • AKRO quarterly operating expenses is now -1.00% below its all-time high of $81.70 million, reached on September 30, 2024.

Performance

AKRO quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

AKRO Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+65.1%+34.9%
3 y3 years+182.9%+210.5%
5 y5 years+525.2%+553.4%

AKRO Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+182.9%-1.0%+218.2%
5 y5-yearat high+525.2%-1.0%+434.6%
alltimeall timeat high+1971.6%-1.0%>+9999.0%

AKRO Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$80.88M(+3.7%)
Dec 2024
$285.42M(+65.1%)
$78.03M(-4.5%)
Sep 2024
-
$81.70M(+24.3%)
Jun 2024
-
$65.74M(+9.7%)
Mar 2024
-
$59.95M(-3.1%)
Dec 2023
$172.87M(+50.1%)
$61.87M(+32.7%)
Sep 2023
-
$46.62M(+30.8%)
Jun 2023
-
$35.63M(+23.9%)
Mar 2023
-
$28.75M(+13.1%)
Dec 2022
$115.16M(+14.1%)
$25.42M(-29.6%)
Sep 2022
-
$36.09M(+30.8%)
Jun 2022
-
$27.59M(+5.9%)
Mar 2022
-
$26.05M(-19.7%)
Dec 2021
$100.89M
$32.44M(+33.2%)
DateAnnualQuarterly
Sep 2021
-
$24.35M(-15.9%)
Jun 2021
-
$28.97M(+91.5%)
Mar 2021
-
$15.13M(-49.2%)
Dec 2020
$80.15M(+75.6%)
$29.78M(+38.3%)
Sep 2020
-
$21.54M(+30.9%)
Jun 2020
-
$16.45M(+32.9%)
Mar 2020
-
$12.38M(-23.7%)
Dec 2019
$45.65M(+231.3%)
$16.22M(-0.5%)
Sep 2019
-
$16.31M(+114.3%)
Jun 2019
-
$7.61M(+38.0%)
Mar 2019
-
$5.51M(+85.7%)
Dec 2018
$13.78M
$2.97M(+71.9%)
Sep 2018
-
$1.73M(-80.1%)
Jun 2018
-
$8.66M(+1957.5%)
Mar 2018
-
$421.00K

FAQ

  • What is Akero Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Akero Therapeutics?
  • What is Akero Therapeutics annual operating expenses year-on-year change?
  • What is Akero Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Akero Therapeutics?
  • What is Akero Therapeutics quarterly operating expenses year-on-year change?

What is Akero Therapeutics annual total operating expenses?

The current annual operating expenses of AKRO is $285.42M

What is the all time high annual operating expenses for Akero Therapeutics?

Akero Therapeutics all-time high annual total operating expenses is $285.42M

What is Akero Therapeutics annual operating expenses year-on-year change?

Over the past year, AKRO annual total operating expenses has changed by +$112.55M (+65.11%)

What is Akero Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of AKRO is $80.88M

What is the all time high quarterly operating expenses for Akero Therapeutics?

Akero Therapeutics all-time high quarterly total operating expenses is $81.70M

What is Akero Therapeutics quarterly operating expenses year-on-year change?

Over the past year, AKRO quarterly total operating expenses has changed by +$20.93M (+34.91%)
On this page